Southern Acids (malaysia) Bhd. · MYX:SAB
Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (August 2016)
19 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Aug 24, 2016
Slide 1: Southern Acids (M) Berhad 35th Annual General Meeting Shareholders Briefing
SOUTHERN ACIDS (M) BERHAD 35TH ANNUAL GENERAL MEETING 24 AUGUST 2016 SHAREHOLDER S BRIEFING 1
Slide 2: Shareholders Briefing Information
Shareholders Briefing Information This briefing is mainly the summary of the key highlights of the Chairman’s Statement and Management Discussion And Analysis as stated in the Company’s 2016 Annual Report (“2016 AR”). Information contained in this briefing is solely based on 2016 AR and all other in
Slide 3: Presentation Contents
Presentation Contents 1. Southern Acids (M) Berhad (“the Company or SAB”) & Its Subsidiaries (“Southern Acids”) Financial Highlights 2. Review Of Core Businesses 3. Prospects 4. Questions & Answers 3
Slide 4: FY2016 Financial Highlights
SOUTHERN ACIDS FY2016 FINANCIAL HIGHLIGHTS 4
Slide 5: Selected Financial Highlights - FY2016 vs FY2015
SELECTED FINANCIAL HIGHTLIGHTS - FY2016 Vs FY2015 FY2016 FY2015 Change (RM’000) (RM’000) 6.2 Revenue 503,414 536,665 % Profit before tax 36,916 43,691 15.5 % Profit for the year 25,964 34,106 23.9 Earnings per % 18.2 sen 20.1 sen 9.5% share Dividend (net) 5.0 sen 5.0 sen No change Dividend pay-out 2
Slide 6: Selected Financial Highlights - FY2016 vs FY2015
SELECTED FINANCIAL HIGHLIGHTS - FY2016 Vs FY2015 FY2016 FY2015 Change (RM’000) (RM’000) Total Assets 626,372 604,922 3.5% Total Liabilities 67,854 65,847 3.0% Net Current Assets 225,424 211,364 6.7 % Equity attributable to Shareholders of 513,942 493,392 the Company 4.2% 6
Slide 7: Southern Acids Financial Results
Southern Acids Financial Results FY2016 FY2015 Varianc Varianc RM’000 RM’000 e e RM’000 % Revenue 503,41 536,66 (33,251 (6.2) 4 5 ) PBT 36,916 43,691 (6,775) (15.5) Highlights:- Revenue was lower by 6.2% in FY2016 compared to FY2015; and PBT was lower by 15.5% in FY2016 compared to FY2015. In su
Slide 8: FY2016 Review of Business Divisions
SOUTHERN ACIDS FY2016 REVIEW OF BUSINESS DIVISIONS 8
Slide 9: Review of Oleochemical Division
Review of Oleochemical Division FY2016 FY2015 Varianc Varianc RM’000 RM’000 e e RM’000 % Revenue 284,02 349,85 (65,830 (18.8) 0 0 ) Highlights:- PBT 16,269 9,038 7,231 80.0 • The 18.8% lower in revenue was mainly due to 15.8% lower in sales volume. The lower demand from major importing countries has
Slide 10: Prospects of Oleochemical Division
Prospects of Oleochemical Division This division will remain to be challenging in FY2017 and it is expected to face the same uncontrollable factors as follow, amongst others:- Economy situation of major importing countries which will determine the market demand and pricing; Higher operating cost
Slide 11: Oleochemical Division's Plan For FY2017
Oleochemical Division’s Plan For FY2017 In view of the anticipated challenges in FY2017, the following are among the key identified measures to be taken:- To implement cost optimization; To increase sales to high margin market via more efficient marketing strategy; and To look into automation
Slide 12: Review of Plantation & Milling Division
Review of Plantation & Milling Division FY2016 FY2015 Variance Variance RM’000 RM’000 RM’000 % Revenue 135,010 106,041 28,969 27.3 PBT 9,101 23,660 (61.5) (14,559) Highlights:- • The increase in revenue was mainly contributed from the new 60MT/hour palm oil mill (“POM”) commissioned in August 2015;
Slide 13: Prospects of Plantation & Milling Division
Prospects Of Plantation & Milling Division The performance of this division in FY2017 will be affected by the following factors, amongst others:- Impact of post-El Nino on FFB production and its quality; Changes in Indonesia’s regulated cost such as minimum wages (yearly affair) and export levy;
Slide 14: Plantation & Milling Division's Plan For FY2017
Plantation & Milling Division’s Plan For FY2017 In view of the anticipated challenges in FY2017, the following are among the key identified measures to be taken:- To implement cost optimization; To purchase external FFB more competitively; To look into mechanization for plantation operations i
Slide 15: Review of Healthcare Division
Review of Healthcare Division FY2016 FY2015 Varianc Varianc RM’000 RM’000 e e RM’000 % Revenue 71,257 66,761 4,496 6.7 PBT Highlights:- 13,529 9,306 4,223 45.4 • The 6.7% higher in revenue was contributed by 11.0% higher in average revenue per patient (“ARPP”); and • Analysis of the RM4.2m increase
Slide 16: Prospects of Healthcare Division
Prospects of Healthcare Division The performance of this division in FY2017 may be affected by the following factors, amongst others:- Competition from nearby hospitals; Recruiting and training the key human resources; and Economic outlook that may affect patients spending behavior. 16
Slide 17: Healthcare Division's Plan For FY2017
Healthcare Division’s Plan For FY2017 The main objective of this division is to at least maintain its market share and improve its bottom line for FY2017. Among the identified measures to be taken are as follows:- Cost optimization; To enhance branding and awareness via strategic marketing activ
Slide 18: Prospects of Southern Acids
Prospects of Southern Acids Based on the prospects commentary, the performance of Southern Acids will remain challenging in FY2017. 18
Slide 19: Questions & Answers
SOUTHERN ACIDS FY2016 QUESTIONS & ANSWERS 19
Southern Acids (M) Berhad — Shareholder Meeting (August 2016) on 6ix